fda glp-1 warning 2025 november Trends In FY Letters Myths & Facts: GLP-1 Drugs
Description
Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.
The decision comes as India is expected to witness a wave of low-cost generics trickle into the #GLP-1 therapy market
Moreover, our analysis of seven patients from the combined therapy group suggests that GLP-1 agonists allow for a reduction in acetazolamide dosage in the treatment of IIH without changing the clinical outcome.
Featured...
This is why it is recommended that the daily usage is incrementally increased so that the body has time to get used to the effects
We're the only one."
